Aptose Biosciences Price To Earning vs. Total Debt
| APS Stock | CAD 0.37 0.01 2.78% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.04 | 1.1 |
|
|
For Aptose Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aptose Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aptose Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aptose Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aptose Biosciences over time as well as its relative position and ranking within its peers.
Aptose |
Aptose Biosciences Total Debt vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aptose Biosciences's current stock value. Our valuation model uses many indicators to compare Aptose Biosciences value to that of its competitors to determine the firm's financial worth. Aptose Biosciences is rated fourth in price to earning category among its peers. It also is rated fourth in total debt category among its peers . As of the 26th of December 2024, Total Debt To Capitalization is likely to drop to 0. Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptose Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptose Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aptose Total Debt vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Aptose Biosciences |
| = | (1.85) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Aptose Biosciences |
| = | 1.01 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Aptose Total Debt vs Competition
Aptose Biosciences is rated fourth in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 8.68 Billion. Aptose Biosciences adds roughly 1.01 Million in total debt claiming only tiny portion of equities under Health Care industry.
Aptose Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aptose Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aptose Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Aptose Biosciences' change in net profit over the period of time. It can combine multiple indicators of Aptose Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.3 M | -4.5 M | |
| Operating Income | -52.4 M | -49.7 M | |
| Net Loss | -51.2 M | -48.6 M | |
| Income Tax Expense | -693 K | -658.4 K | |
| Income Before Tax | -51.2 M | -48.6 M | |
| Total Other Income Expense Net | 1.1 M | 1.2 M | |
| Net Loss | -51.2 M | -48.6 M | |
| Net Loss | -37.6 M | -39.5 M | |
| Interest Income | 1.2 M | 577.1 K | |
| Net Interest Income | 1.2 M | 1.2 M | |
| Change To Netincome | 23.5 M | 24.7 M | |
| Net Loss | (7.58) | (7.96) | |
| Income Quality | 0.87 | 0.62 | |
| Net Income Per E B T | 0.88 | 0.79 |
Aptose Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aptose Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aptose Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aptose Biosciences' important profitability drivers and their relationship over time.
Use Aptose Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Aptose Biosciences Pair Trading
Aptose Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aptose Biosciences position
In addition to having Aptose Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
To fully project Aptose Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aptose Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aptose Biosciences' income statement, its balance sheet, and the statement of cash flows.